Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-NF-κB Pathway-IκB kinase (IKK)-AZ13102909
AZ13102909

Chemical Structure : AZ13102909

CAS No.: 2322365-47-7

AZ13102909 (AZ909)

Catalog No.: PC-38528Not For Human Use, Lab Use Only.

AZ13102909 (AZ909) is a potent and selrctive TBK1 inhibitor with IC50 of 5 nM, 100-1000 fold greater for other related kinases.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    AZ13102909 (AZ909) is a potent and selrctive TBK1 inhibitor with IC50 of 5 nM, 100-1000 fold greater for other related kinases.
    AZ909 combines with AZD6244 to enhance apoptosis in AZD6244-resistant lines in 3D culture.

    Physicochemical Properties

    M.Wt 569.548
    Formula C28H37BrN6O2
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    N-(3-((6-bromo-2-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)amino)propyl)cyclopentanecarboxamide

    References

    1. Xu J, et al. Sci Rep. 2018 Oct 22;8(1):15587.

    2. Vu HL, Molecular cancer research: MCR. 2014;12:1509–1519.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: